Evidence map›Paper›PMID 38878644›Full record

ArticleAddictive behaviors2024

Cannabis use trajectories over time in relation to minority stress and gender among sexual and gender minority people.

Annesa Flentje, Gowri Sunder, Alexis Ceja, Nadra E Lisha, Torsten B Neilands, Bradley E Aouizerat, Micah E Lubensky, Matthew R Capriotti, Zubin Dastur, Mitchell R Lunn and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Addictive behaviors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Annesa FlentjeCommunity Health Systems, School of Nursing, University of California, San Francisco, CA, United States; Alliance Health Project, Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, San Francisco, CA, United States; The PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States. Electronic address: Annesa.Flentje@ucsf.edu.
Gowri SunderCommunity Health Systems, School of Nursing, University of California, San Francisco, CA, United States; The PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States.
Alexis CejaCommunity Health Systems, School of Nursing, University of California, San Francisco, CA, United States; The PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States.
Nadra E LishaCenter for Tobacco Control and Research and Education, University of California, San Francisco, CA, United States; Division of Prevention Science, Department of Medicine, University of California, San Francisco, CA, United States.
Torsten B NeilandsDivision of Prevention Science, Department of Medicine, University of California, San Francisco, CA, United States.
Bradley E AouizeratCollege of Dentistry, Translational Research Center, New York University, New York, NY, United States; Rory Meyers College of Nursing, New York University, New York, NY, United States.
Micah E LubenskyCommunity Health Systems, School of Nursing, University of California, San Francisco, CA, United States; The PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States.
Matthew R CapriottiDepartment of Psychology, College of Social Sciences, San José State University, San José, CA, United States.
Zubin DasturThe PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, United States.
Mitchell R LunnThe PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, United States.
Juno Obedin-MaliverThe PRIDE Study/PRIDEnet, Stanford University School of Medicine, Stanford, CA, United States; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, United States; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, United States.

Funding

UCSF-Kaiser Urological Epidemiology Research Career Development ProgramK12DK111028 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ALISON · 2016 to 2025
$5.3M
Substance use and DNA methylation at the intersection of sex and genderR01DA052016 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FLENTJE, ANNESA · 2020 to 2023
$2.9M
NIDA NIH HHS R01 DA052016NIDDK NIH HHS K12 DK111028
6 · The paper itself

Abstract

Substance use disparities among sexual and gender minority (SGM) people are attributed to minority stress, but few studies have examined minority stress and cannabis use over time or investigated differences in cannabis use trajectories by less-studied gender subgroups. We examined if longitudinal cannabis use trajectories are related to baseline minority stressors and if gender differences persisted after accounting for minority stress. Cannabis use risk was measured annually over four years (2017-2021) within a longitudinal cohort study of SGM adults in the United States (N = 11,813). Discrimination and victimization, internalized stigma, disclosure and concealment, and safety and acceptance comprised minority stress (n = 5,673). Latent class growth curve mixture models identified five cannabis use trajectories: 'low or no risk', 'low moderate risk', 'high moderate risk', 'steep risk increase', and 'highest risk'. Participants who reported past-year discrimination and/or victimization at baseline had greater odds of membership in any cannabis risk category compared to the 'low risk' category (odds ratios [OR] 1.17-1.33). Internalized stigma was related to 'high moderate' and 'highest risk' cannabis use (ORs 1.27-1.38). After accounting for minority stress, compared to cisgender men, gender expansive people and transgender men had higher odds of 'low moderate risk' (ORs 1.61, 1.67) or 'high moderate risk' (ORs 2.09, 1.99), and transgender men had higher odds of 'highest risk' (OR 2.36) cannabis use. This study indicates minority stress is related to prospective cannabis use risk trajectories among SGM people, and transgender men and gender expansive people have greater odds of trajectories reflecting cannabis use risk.

Indexed as

Crime VictimsMarijuana UseSexual and Gender MinoritiesSocial StigmaStress, PsychologicalAdolescentAdultFemaleHumansLongitudinal StudiesMaleMiddle AgedMinority GroupsSex FactorsUnited StatesYoung AdultCannabis useLongitudinalMinority stressSexual and gender minoritySubstance use risk

Identifiers

PMID38878644
PMCPMC12197853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.